Biotech

Genetic Technologies Executes Settlement and License Agreement With Eurofins STA Laboratories, Inc.

MELBOURNE, AUSTRALIA: ...

Proteonomix, Inc. (PROT) Brings in Additional Leadership in Order to Expand Management

MOUNTAINSIDE, NJ: ...

Celsion to Present at the 14th Annual BIO CEO & Investor Conference

LAWRENCEVILLE, NJ: ...

SciClone Pharmaceuticals to Present at BIO CEO & Investor Conference

FOSTER CITY, CA: ...

McKesson Corporation Acquires Proventys' Advanced Decision Support Assets in Oncology

NEWTON, MA: ...

Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302

SOUTH SAN FRANCISCO, CA: ...

Cytokinetics, Incorporated Reports Fourth Quarter and Year End Highlights and 2011 Financial Results

SOUTH SAN FRANCISCO, CA: Company Provides Financial Guidance and Expected Milestones for 2012; Ongoing Phase II Trials of Omecamtiv Mecarbil and CK-2017357 Inform Next Steps in Clinical Development Programs ...

Prana Comments on Nature Medicine, PNAS and Journal of Alzheimer's Disease Articles That Highlight the Role of Metals in Neurological Diseases

MELBOURNE, AUSTRALIA: ...

Dynavax Reports on Heplisav(TM) Pre-BLA Meeting With FDA

BERKELEY, CA: ...

AVI BioPharma to Present Company Overview at the 14th Annual BIO CEO & Investor Conference

BOTHELL, WA: Webcast Accessible via AVI Website ...